KCT0008377招募中未知
Safety and efficacy of 1-month dual antiplatelet therapy in high bleeding and ischemic risk elderly patients with coronary artery disease after implantation of zotarolimus-eluting coronary stent system (Resolute Onyx™ , Medtronic, Minneapolis, MN); A multicenter, prospective, observational study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 75(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •75 years of age or older who underwent percutaneous coronary intervention using Resolute Onyx stents an aged patient.
排除标准
- •- If DAPT therapy cannot be followed for a month
- •- If additional surgery is required
- •- If you have a non-cardiac comorbid disease with a life expectancy of less than one year
- •- If there is a taboo against aspirin or P2Y12 inhibitors
研究者
相似试验
招募中
3 期
Outcomes of 1-month vs 3-month dual antiplatelet therapy in high bleeding risk patients after percutaneous coronary intervention, a randomized controlled trialTCTR20211024003Faculty of Medicine, Chiang Mai University502
已完成
不适用
Impact of 1-month Dual Antiplatelet Therapy After Treatment with Drug-Coated Balloon for Femoropopliteal Artery DiseaseArteriosclerosis obliteransJPRN-UMIN000034867Hyogo College of Medicine151
招募中
不适用
The Study to Evaluate the Safety and Efficacy of the Onyx FamilyCoronary Artery DiseaseNCT06577896Pusan National University Yangsan Hospital500
尚未招募
不适用
One-Month Dual Antiplatelet Therapy followed by P2Y12 Inhibitor Monotherapy After Biofreedom Ultra® Stent Implantation in Patients with Acute Coronary Syndrome: DAPT-FREE TRIAKCT0006530Chonnam National University Hospital1
尚未招募
不适用
Effect of potent P2Y12 inhibitor monotherapy after double antiplatelet therapy for 1 month after PCI in ACS patientsDiseases of the circulatory systemKCT0006861Chonnam National University Hospital2,000